Aravive Inc (ARAV) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aravive Inc   (NASDAQ: ARAV)


Aravive Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aravive Inc's ROI in the third quarter of 2023?
Aravive Inc recorded a cumulative net loss of $-40 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -205.18%.

Within the Healthcare sector 900 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 4593, from total ROI ranking in the second quarter of 2023 at 4741.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -49.81 % -53.29 % -51.36 % -45.14 % -43.23 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 12 23 40 18
Return On Investment (TTM) -205.18 % -330.4 % -391.07 % -210.59 % -155.46 %
ARAV's Overall Ranking # 4593 # 4741 # 2749 # 4773 # 0
Seq. Investment Change TTM -16.38 % -19.78 % -20.12 % -6.34 % -22.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -40 -77 -113 -76 -60

ARAV Company Profile >> Back to ARAV Roi Comparisons >> See Annual ARAV Return On Investment



Return On Investment ARAV's Ranking
Within: No.
Industry # 436
Sector # 901
Overall # 4593

Return On Investment Statistics
High Average Low
7.21 %
-85.27 %
-391.07 %
(Sep 30 2018)   (Mar 31 2023)







Financial Statements
Aravive Inc's III. Quarter Investments $ 3 Millions ARAV's Balance sheet
Aravive Inc's III. Quarter Income $ 21 Millions Quarterly ARAV's Income Statement
ARAV's Income by Division See ARAV's Income by Division


ARAV Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 40 50 58 77 68
Y / Y Investment Growth -19.67 % -14.43 % -24.5 % 14.24 % -23.42 %
Net Income in Millions -76 -39 -31 -18 -76
Y / Y Net Income Growth - - - - -
Annual Return On Investment -190.61 % -78.54 % -52.44 % -23.61 % -113.03 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARAV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARAV's Competitors
Subscribers only: Roi for Aravive Inc's Suppliers
Subscribers only: Return On Investment for ARAV's Customers

Other Ratios
ARAV's Roa ARAV's Inventory Turnover Ratio ARAV's Growth Rates ARAV's Dividend Statistics
ARAV's Profitability Ratios ARAV's Asset Turnover Ratio ARAV's Dividend Growth
ARAV's Roe ARAV's Valuation Ratios ARAV's Financial Strength Ratios ARAV's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-26T07:02:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.